Impact of baseline conduction abnormalities on outcomes after transcatheter aortic valve replacement with SAPIEN-3

Yasser Sammour1, Kimi Sato1, Arnav Kumar1

  • 1Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Insights

Right bundle branch block and first-degree atrioventricular block are key predictors for permanent pacemaker implantation after TAVR. Preexisting atrial fibrillation increases risks for mortality, stroke, and major adverse cardiac events post-TAVR.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Electrophysiology

Background:

  • Conduction abnormalities are established risk factors for permanent pacemaker (PPM) implantation following transcatheter aortic valve replacement (TAVR).
  • Understanding the specific impact of baseline conduction defects on TAVR outcomes is crucial for patient management.

Purpose of the Study:

  • To investigate the influence of baseline conduction abnormalities, including right bundle branch block (RBBB), left bundle branch block (LBBB), left anterior hemiblock (LAHB), first-degree atrioventricular block (AVB), and atrial fibrillation/flutter (AF), on TAVR outcomes.
  • To identify independent predictors of PPM implantation and assess the long-term effects of these conduction defects on left ventricular ejection fraction (LVEF), major adverse cardiac and cerebrovascular events (MACCE), and mortality.

Main Methods:

  • A cohort of 886 consecutive patients undergoing transfemoral TAVR with SAPIEN-3 (S3) were analyzed.
  • Patients with prior PPM, nontransfemoral access, or valve-in-valve procedures were excluded.
  • Statistical analysis was performed to determine the association between baseline conduction abnormalities and 30-day PPM, as well as long-term outcomes including LVEF, stroke/TIA, MACCE, and mortality.

Main Results:

  • Baseline RBBB (OR 4.005) and first-degree AVB (OR 1.847) were independent predictors of 30-day PPM implantation.
  • Baseline LBBB and AF were associated with lower LVEF at baseline and 1 year post-TAVR, though changes in LVEF over time were similar.
  • Preexisting AF was linked to increased rates of stroke/TIA (4.4%), 1-year MACCE (19.5%), and 2-year mortality (23.5%) compared to patients without AF.

Conclusions:

  • In the S3 TAVR population, RBBB and first-degree AVB are significant predictors of higher PPM risk.
  • Preexisting LBBB and AF are associated with reduced LVEF post-TAVR.
  • Baseline AF independently predicts worse long-term outcomes, including increased mortality, stroke/TIA, and MACCE.
Abstract